In the present study, we confirmed that Rh2 exhibits inhibition of proliferation, invasion, and migration in NSCLC cells and demonstrated that Rh2 suppresses aerobic glycolysis of NSCLC cells via the STAT3/c-Myc axis (Figure 7). Here, MYC is linked to non-small cell lung carcinoma.